Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...
Isomorphic Labs was founded to apply artificial intelligence to drug discovery. The company is led by AI researcher Sir Demis Hassabis.
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...